Morpholino

MO1-nr3c1

ID

ZDB-MRPHLNO-080229-4

Name

MO1-nr3c1

Previous Names

GR MO

Target

nr3c1 (1)

Sequence

5' - CGGAACCCTAAAATACATGAAGCAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice blocking morpholino.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-nr3c1

Expressed Gene	Anatomy	Figures
atp6v1aa	whole organism	Fig. 3, Fig. 4 from Lin et al., 2015
atp6v1ab	vH ionocyte	Fig. 2 from Cruz et al., 2013
ca2	whole organism	Fig. 3, Fig. 4 from Lin et al., 2015
ca15a	whole organism	Fig. 3, Fig. 4 from Lin et al., 2015
nr3c1	whole organism	Fig. 5 from Mathew et al., 2007
slc4a1b	whole organism	Fig. 3, Fig. 4 from Lin et al., 2015
slc9a3.2	whole organism	Fig. 3, Fig. 4 from Lin et al., 2015

Phenotype

Phenotype resulting from MO1-nr3c1

Phenotype	Fish	Figures
integument proton export across plasma membrane decreased occurrence, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015
NaK ionocyte decreased amount, abnormal	WT + MO1-nr3c1	Fig. 1 from Cruz et al., 2013
proton export across plasma membrane decreased occurrence, abnormal	WT + MO1-nr3c1	Fig. 3 from Lin et al., 2015
vH ionocyte decreased amount, abnormal	WT + MO1-nr3c1	Fig. 2 from Cruz et al., 2013
whole organism slc4a1b expression decreased amount, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism ca15a expression decreased amount, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism atp6v1aa expression decreased amount, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism ca2 expression decreased amount, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism slc9a3.2 expression decreased amount, abnormal	WT + MO1-nr3c1	Fig. 3, Fig. 4 from Lin et al., 2015

Phenotype of all Fish created by or utilizing MO1-nr3c1

Phenotype	Fish	Conditions	Figures
liver size, exacerbated	TL + MO1-nr3c1	chemical treatment by environment: dexamethasone	Fig. 2 from Yin et al., 2017
whole organism ca15a expression decreased amount, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism ca2 expression increased amount, abnormal	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
whole organism slc9a3.2 expression increased amount, abnormal	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
whole organism slc9a3.2 expression decreased amount, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism ca15a expression amount, ameliorated	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
whole organism slc4a1b expression amount, ameliorated	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
vH ionocyte decreased amount, abnormal	WT + MO1-nr3c1	standard conditions	Fig. 2 from Cruz et al., 2013
whole organism ca2 expression decreased amount, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism slc4a1b expression decreased amount, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015
whole organism atp6v1aa expression amount, ameliorated	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
proton export across plasma membrane decreased occurrence, abnormal	WT + MO1-nr3c1	control	Fig. 3 from Lin et al., 2015
NaK ionocyte decreased amount, abnormal	WT + MO1-nr3c1	standard conditions	Fig. 1 from Cruz et al., 2013
whole organism atp6v1aa expression decreased amount, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015
integument proton export across plasma membrane occurrence, ameliorated	WT + MO1-nr3c1	acidic	Fig. 5 from Lin et al., 2015
integument proton export across plasma membrane decreased occurrence, abnormal	WT + MO1-nr3c1	control	Fig. 3, Fig. 4 from Lin et al., 2015

Citations